A lzheimer's Disease (AD) is defi ned histopathologically by extracellular β-amyloid (Aβ) fi brils plus intraneuronal tau fi laments. Studies of transgenic mice and cultured cells indicate that AD is caused by a pathological cascade in which Aβ lies upstream of tau, but the steps that connect Aβ to tau have remained undefi ned. We demonstrate that tau confers acute hypersensitivity of microtubules to prefi brillar, extracellular Aβ in nonneuronal cells that express transfected tau and in cultured neurons that express endogenous tau. Prefi brillar Aβ42 was active at submicromolar concentrations, severalfold below those required for equivalent effects of prefibrillar Aβ40, and microtubules were insensitive to fi brillar Aβ. The active region of tau was localized to an N-terminal domain that does not bind microtubules and is not part of the region of tau that assembles into fi laments. These results suggest that a seminal cell biological event in AD pathogenesis is acute, tau-dependent loss of microtubule integrity caused by exposure of neurons to readily diffusible Aβ.
Introduction
Insoluble deposits of β-amyloid (Aβ), in the form of senile plaques, and of tau, as neurofi brillary tangles, have long been accepted as the primary histopathological markers of Alzheimer's disease (AD). Although initial research focused on the role of Aβ and tau individually, recent evidence, including data demonstrating that amyloid pathology can up-regulate tau pathology (Gotz et al., 2001; Lewis et al., 2001) , defi nes a signaling pathway that leads from Aβ through tau (Lee et al., 2001; Selkoe, 2001; Hardy and Selkoe, 2002) . Regrettably, the key steps within this pathway remain poorly understood.
A promising new focus of investigation has been the role that nonfi brillar forms of Aβ, and to a lesser extent tau, play in AD. Soluble forms of Aβ are more potent than fi brillar forms at eliciting cellular responses, such as increased apoptosis (Sponne et al., 2003) and decreased synaptic plasticity (Walsh et al., 2002) . In fact, studies of transgenic animal models and AD patients have shown that cognitive defi cits and synaptic loss correlate with soluble Aβ, rather than senile plaques (Kayed et al., 2003; Oddo et al., 2006) , suggesting that AD is initiated well before extracellular Aβ deposits are evident.
Neuronal microtubules serve as highways for axonal transport and, by extension, are critically involved in supporting synaptic integrity and neuronal viability. The loss of axonal microtubules is a hallmark of AD, and a longstanding question has been whether their loss or the accumulation of insoluble tau fi laments and Aβ plaques causes neurodegeneration. To shed light on this issue, we have used cultured neuronal and nonneuronal cells to model effects of various forms of Aβ on microtubules. Remarkably, we found that brief exposure of cells to submicromolar levels of prefi brillar Aβ42 caused massive and rapid taudependent disassembly of microtubules. Similar results were obtained for prefi brillar Aβ40, albeit at much higher concentrations, but microtubules in either tau-expressing or -defi cient cells were relatively resistant to fi brillar Aβ. Collectively, these results highlight the most dramatic, rapid, and sensitive link between Aβ and tau described to date, identify microtubules as primary, tau-dependent targets of Aβ, and suggest that nonfi brillar Aβ and tau underlie the detrimental neurodegeneration observed in AD before the accumulation of fi brillar forms in senile plaques and neurofi brillary tangles.
Results and discussion
Coexpression of tau-CFP and YFP-tubulin in CV-1 African green monkey kidney cells, which do not express endogenous tau, allowed effects of various forms of Aβ on tau and tubulin distributions to be monitored in live cells by time-lapse fl uorescence microscopy. Aβ is known to transition gradually from monomers to oligomers, protofi brils, and fi nally to highly stable fi brils (Bitan et al., 2003) . Because we did not observe any consistent differences in behavior between freshly solubilized Aβ42, which is predominantly monomeric, versus Aβ42 enriched in octamers and larger oligomers that are recognized by a specifi c antibody (Kayed et al., 2003) , we refer to these forms of Aβ42 collectively as "prefi brillar." It must be noted, however, that oligomers were readily detectable in freshly solubilized Aβ42 (Fig. S1 , available at http://www.jcb.org/cgi/content/ full/jcb.200605187/DC1). Within 30 min to 3 h after adding 0.1-3 μM prefi brillar Aβ42 to culture media, tau dissociated from microtubules, which completely disassembled soon thereafter ( Fig. 1 A and Video 1). Prefi brillar Aβ40 was also capable of inducing tau-dependent microtubule disassembly in CV-1 cells, but at a minimum concentration of 3 μM (Video 2). In contrast, microtubules remained intact for >3 h when CV-1 cells expressing YFP-tubulin, but not tau-CFP, were exposed to as much as 3 μM prefi brillar Aβ42 ( Fig. 1 B and Video 3). Similarly, microtubule integrity was unaffected in cells expressing tau-CFP after >2 h of exposure to as much as 3 μM fi brillar Aβ42 (Fig. 1 C and Video 4) . Microtubule stability before and after exposure of cells to prefi brillar Aβ42 was also assessed using a biochemical assay that partitions unassembled and polymerized tubulin into Triton X-100-soluble and -insoluble fractions, respectively (Black et al., 1996) . Prefi brillar Aβ42 led to a dramatic redistribution of tubulin into the unassembled fraction within 2 h of treatment (Fig. 1 D) . This result was reinforced by quantitation of micrographs depicting Aβ42-induced microtubule loss in cells that did or did not express tau-CFP (Fig. 1 E) . We thus conclude that tau makes CV-1 cell microtubules hypersensitive to prefi brillar Aβ peptides, particularly Aβ42, but not to fi brillar Aβ42. Microtubule disassembly was also observed in primary rat cortical neurons after exposure to prefi brillar Aβ42. Discrimination between polymerized and disassembled tubulin was not evident from immunostaining of the treated neurons. Nevertheless, the immunofl uorescence images show that before prefi brillar Aβ42 addition, the cells displayed numerous neuritic projections (Fig. 2 A) . After only 30 min of cellular exposure to 1 μM prefibrillar Aβ42, the neurites displayed swollen varicosities, and at later time points the cells appeared to lose the majority of their neuritic projections. Similar cultures were examined by electron microscopy (Fig. 2 B) . Neurites in control cells typically contained densely packed microtubules arranged in parallel. In contrast, neurites in cells treated with prefi brillar Aβ42 contained fewer, less organized microtubules and conspicuous swellings that were fi lled with membrane-bound organelles and were virtually devoid of microtubules. Similar fi ndings have been reported for primary cortical neurons exposed to 5 μM oligomeric Aβ40 for 3-6 h (Sponne et al., 2003; Fifre et al., 2006) .
The biochemical assay for unassembled and polymerized tubulin (Black et al., 1996) was used to monitor the effects of Figure 1 . Tau-dependent hypersensitivity of CV-1 cell microtubules to prefi brillar A 42. CV-1 cells transfected with tau-CFP and YFPtubulin were treated with prefi brillar Aβ42 as indicated and imaged by time-lapse fl uorescence microscopy or analyzed by a biochemical assay for unassembled and polymerized tubulin (Black et al., 1996) . (A) 1 μM prefi brillar Aβ42 caused tau to dissociate from microtubules and the microtubules to disassemble soon thereafter. (B) This effect required tau expression, because microtubules remained intact in cells that expressed only YFP-tubulin and were treated with 3 μM prefi brillar Aβ42. (C) Microtubules were unaffected in tauexpressing cells exposed to 3 μM fi brillar Aβ42. (D and E) Time-dependent microtubule loss induced by prefi brillar Aβ42 documented in D by fractionation of tubulin into soluble (S) and polymerized (P) pools (Black et al., 1996) , and quantitation of fl uorescence micrographs of fi xed cells expressing Tau-CFP and counterstained with anti-α-tubulin (E). Error bars indicate the SD, and transfected and nontransfected refer to cells that did and did not express Tau-CFP, respectively. prefi brillar and fi brillar Aβ42 on microtubule integrity in cultured hippocampal neurons (Fig. 2 C) . About 90% of the tubulin was polymerized in cells that were not exposed to Aβ42, but only 45% of the tubulin was polymerized after 2 h of exposure to 1 μM prefi brillar Aβ42. Some microtubule loss (65% polymerized) was observed after a comparable exposure to fi brillar Aβ42, but only at the much higher total peptide concentration of 3 μM.
Tau was found to be required for microtubule disassembly in primary hippocampal neurons induced by prefibrillar Aβ42. Neurons were treated with siRNA to reduce tau expression to trace levels ( After 2 h of exposure to 2 μM prefi brillar Aβ42, the level of polymerized tubulin remained nearly unchanged in tau-defi cient neurons ‫%02ف(‬ soluble tubulin), whereas the tau-expressing neurons again showed an increase in soluble tubulin ‫%06ف(‬ soluble tubulin). It was not possible to determine how much tau was microtubule bound or soluble in these experiments, because the tau was quantitatively solubilized by the Triton X-100 under conditions in which the polymerized tubulin was resistant to extraction (Black et al., 1996) . Thus, the results for tubulin demonstrate that the endogenous tau in neurons, like transfected tau in CV-1 cells, makes microtubules acutely sensitive to prefi brillar Aβ42.
Treatment of tau-expressing neurons with prefi brillar Aβ42 under conditions that induced microtubule disassembly did not cause increased AD-like tau phosphorylation at any of several sites (Fig. 3) . This was found by immunoblotting using phosphorylation-sensitive monoclonal anti-tau antibodies: PHF-1, AT180, and tau-1. Although many additional AD-like Figure 2 . Tau-dependent hypersensitivity of neuronal microtubules to prefi brillar A 42. Primary rat cortical neurons were cultured for at least 8 d before treatment with prefi brillar Aβ42. (A) Cells were stained by immunofl uorescence for tubulin (DM1A) and tau (R1tau) at the time points indicated after the addition of 1 μM prefi brillar Aβ42. Note the swollen varicosities induced by the Aβ42 (arrows). (B) Neurites in neurons treated for 2 h with 1 μM prefi brillar Aβ42 were found by electron microscopy to contain numerous varicosities that were fi lled with membrane-bound organelles (asterisks) and lacked microtubules, and additional regions with sparse, poorly organized microtubules (arrowheads). (C) Primary hippocampal neurons were extracted with Triton X-100 to separate the soluble (S) from polymerized (P) tubulin (Black et al., 1996) . Note that ‫%09ف‬ of the tubulin was polymerized in control cultures, that only ‫%54ف‬ was polymerized after 2 h of cellular exposure to 1 μM prefi brillar Aβ42, and that only a modest loss of polymerized tubulin (65% polymerized) was caused by a 2-h exposure to 3 μM fi brillar Aβ42. (D) Primary neurons were transfected with a tau-specifi c siRNA and treated with 2 μM prefi brillar Aβ42 for 2 h before extraction. The siRNAtreated cells expressed between 1/16 and 1/32 the normal level of tau (see Fig. S1 , available at http://www.jcb.org/cgi/ content/full/jcb.200605187/DC1) and showed no change in tubulin levels in response to the Aβ42 treatment when compared with the tau-expressing cells. phosphorylation sites remain to be examined, these data suggest that conversion of tau to an AD-like phosphorylation state does not underlie the release of tau from microtubules and subsequent microtubule disassembly induced by prefi brillar Aβ42.
The specifi city of tau for microtubule loss in cells treated with prefi brillar Aβ42 was shown by expressing GFP-tagged MAP2c in CV-1 cells. MAP2c is a neuron-specifi c microtubuleassociated protein with a microtubule binding domain ‫%07ف‬ identical to that of tau's (Dehmelt and Halpain, 2005) . 3 h of exposure to prefi brillar Aβ42 did not cause any apparent loss of microtubule integrity in cells. A region of tau responsible for conferring sensitivity to Aβ42 was mapped using a combination of tau/MAP2c chimeric proteins and a CFP-tagged tau fragment. Only cells expressing "tau chimera," a GFP-tagged protein comprising the microtubule binding domain of MAP2c fl anked by the N-terminal arm and C-terminal tail of tau (Fig. 4 B and Videos 5-7, available at http://www.jcb.org/cgi/content/ full/jcb.200605187/DC1) responded to the addition of prefi brillar Aβ42. Similar activity was observed when the tau projection domain-CFP, which did not localize on microtubules, was expressed in cells that subsequently were treated with prefi brillar Aβ42 (Fig. 4 B and Video 8) . The qualitative results shown in Fig. 4 and Videos 1 and 4-8 were confi rmed by quantitation of fl uorescence micrographs for microtubule-containing cells before and after 3 h of exposure to prefi brillar Aβ42 (Fig. 5) . The N-terminal half of tau therefore responds to prefi brillar Aβ42 and does not have to target to microtubules to exert its effects. Furthermore, the closely related neuronal microtubule protein, MAP2c, cannot substitute for tau at promoting microtubule disassembly in cells exposed to prefi brillar Aβ42.
The nature of the functional connection between Aβ and tau has been one of the most enduring and intractable mysteries in AD research, and solving this mystery is bound to open potential new avenues of early detection and therapeutic intervention for AD. The results presented here represent the swiftest and most deleterious tau-dependent effects of Aβ that have yet been described. When considered together with recently published studies demonstrating localization of oligomeric Aβ in AD brain at sites distinct from classic amyloid plaques (Kayed et al., 2003) , a critical role for oligomeric Aβ in memory loss (Lesne et al., 2006) , and colocalization of Aβ with tau in tanglebearing AD neurons in vivo (Guo et al., 2006) , the present results suggest a mechanism by which Aβ and tau conspire coordinately to compromise neuronal function. Diminished microtubule integrity could hinder essential microtubule functions, such as axonal transport, which is required to maintain synapses, and delivery of exocytotic membranes to the cell surface to repair plasma membrane holes (Shen et al., 2005) known to be induced by oligomeric Aβ (Kayed et al., 2003) . The biochemical steps that underlie tau-dependent microtubule poisoning by prefi brillar Aβ remain unknown, but direct binding of tau to Aβ has been reported (Guo et al., 2006) and thus represents one possible step. Nevertheless, we have been unable to demonstrate specifi c coimmunoprecipitation of tau and Aβ out of tauexpressing cells exposed to prefi brillar Aβ42.
That the combination of prefi brillar Aβ and nonfi lamentous tau were able to elicit such a dramatic disruption of microtubules supports the hypothesis that fi brillar forms of tau and Aβ are at least somewhat neuro-protective, because they sequester more dangerous, nonfi brillar forms of Aβ and tau (Tanzi, 2005) . The fact that tau is required for Aβ-induced microtubule loss could explain, at least in part, why neurons, the principal tauexpressing cell type, are the cellular targets for destruction in AD. Moreover, the model presented here does not preclude other toxic functions of prefi brillar or fi brillar Aβ or fi lamentous tau, such as tau-dependent degeneration of cultured neurons induced by fi brillar Aβ40 (Rapoport et al., 2002) or toxicity related to intracellular tau fi lament accumulation (Khlistunova et al., 2006) . Nevertheless, the rapid, tau-dependent destruction of microtubules that we observed to be induced by submicromolar concentrations of prefi brillar Aβ42 suggests that this process is one of the seminal events in AD pathogenesis at the cellular level.
Materials and methods

Antibodies
Tau-5, Tau-1, and R1 anti-tau antibodies were gifts from L. Binder (Northwestern University Medical School, Chicago, IL), and PHF-1 anti-tau was provided by P. Davies (Albert Einstein College of Medicine, New York, NY). AT180 anti-tau (Pierce Chemical Co.), DM1A anti-α-tubulin (SigmaAldrich), C4 anti-actin (Chemicon), 6E10 anti-Aβ (Signet; recognizes all forms of Aβ40 and Aβ42), fl uorescently tagged goat anti-mouse IgG and goat anti-rabbit (Southern Biotechnology Associates, Inc.) and HRP-labeled goat anti-mouse IgG (KPL) were acquired from the indicated commercial sources. I-11 is one of the Glabe laboratory's rabbit polyclonal antibodies against oligomeric Aβ (Kayed et al., 2003) .
Cell culture CV-1 (African green monkey kidney) cells were cultured in DME (Invitrogen) supplemented with 10% Cosmic Calf Serum (Hyclone) and 50 μg/ml gentamycin. Cells were transiently transfected using Fugene (Roche) or a nucleofector (Amaxa) with cDNAs for the longest human isoform of tau or the projection domain (amino acids 1-248) of tau linked at their C terminals to ECFP or EYFP (CLONTECH Laboratories, Inc.); with YFP-α-tubulin (CLONTECH Laboratories, Inc.); or with MAP2c or MAP2c/tau chimeras (Roger et al., 2004) tagged at their N termini with GFP, which were gifts from S. Halpain (The Scripps Research Institute, La Jolla, CA). For nucleofection, program A-033 and solution V were used according to the manufacturer's instructions. Primary cortical neurons were purchased from Genlantis and cultured according to their guidelines. Primary hippocampal neurons (Wisco et al., 2003) were grown for at least 8 d before Aβ treatment. The tau siRNA (SMARTpool; Dharmacon) and control scrambled siRNA (Nonspecifi c duplex II; Dharmacon) were transfected into primary hippocampal neurons by nucleofection using the rat neuron solution (Amaxa) and program G-13 (Qiang et al., 2006) . Cells were cultured for 4 d after nucleofection and were then exposed to Aβ.
A treatment
Previously described methods were used to synthesize (Burdick et al., 1992) and resuspend (Kayed et al., 2003) Aβ42 and Aβ40. The Aβ was added to cells cultured in serum-free DME to fi nal concentrations from 0.1 to 5 μM. Prefi brillar Aβ was used in the fi rst and second days after resuspension, whereas fi brillar Aβ was used after at least 7 d of stirring.
Microscopy
Live cell imaging and immunofl uorescence microscopy were performed as previously described (Mateer et al., 2002) on an Axiovert 100 (Carl Zeiss MicroImaging, Inc.) equipped with 63× 1.4 NA planapo and 25× 0.8 NA plan-neofl uar objectives (Carl Zeiss MicroImaging, Inc.), a CARV spinning disk confocal head (BD Biosciences), an X-Cite 120 illuminator (EXFO Photonic Solutions), a cooled charge-coupled device (Orca ER; Hamamatsu), and OpenLab software (Improvision) for image acquisition and processing. For live cell time-lapse imaging, the cells were maintained on the microscope stage in DME at 37°C in an atmosphere of 95% air and 5% CO 2 . The supplemental time-lapse videos were produced by fi rst using the public domain software, ImageJ to pseudocolor eight-bit grayscale images stacks to eight-bit cyan, green, or yellow image stacks, and then using QuickTime Pro 7 and Keynote 3 (Apple) to produce self-playing videos compressed with the H.264 codec. For electron microscopy, primary cortical and hippocampal neurons were grown on glass coverslips, treated with Aβ42, and fi xed in 2.5% glutaraldehyde plus 0.5% tannic acid in 0.1 M cacodylate buffer, pH 7.4. Cells on coverslips were dehydrated and capsule embedded in EPON, and the glass coverslip was removed from the EPON by alternating liquid nitrogen and warm water submersion of the capsule. Sectioned samples were viewed on an electron microscope (JEM 1010; JEOL) at 80 kV, and images were captured using a 16-megapixel cooled charge-coupled device (SAI-12c; Scientifi c Instruments and Applications, Inc).
Quantitation of fl uorescence micrographs
Nucleofection was used to express fusion proteins of CFP, GFP, or YFP coupled to tau, the N-terminal tau arm, MAP2c, or MAP2c/tau chimeras in CV-1 cells growing on glass coverslips. Cultures that either were or were not exposed to prefi brillar or fi brillar Aβ42 for 3 h were fi xed and permeabilized for 5 min in −20°C methanol and stained for immunofl uorescence with anti-α-tubulin followed by TRITC-labeled goat anti-mouse IgG. For each coverslip, six randomly chosen fi elds of view were photographed separately in both the TRITC channel and the CFP, GFP, or YFP channel using the 25× objective. Typically, 40-50% of the total cells expressed the transfected protein. Next, without knowing the identity of the sample, an observer counted the total cells and microtubule-containing cells in one anti-tubulin fi eld and then counted the total number of transfected cells and microtubule-containing transfected cells in the same fi eld. This process was repeated for the remaining fi elds of the coverslip, and the results from all six fi elds, which comprised ‫005ف‬ total cells, were merged into a single dataset. Each such experiment was performed in triplicate, and the net results were graphed in Figs. 1 E and 5 as the mean ± SD of the percentage of microtubule-containing transfected and nontransfected cells for each experimental condition. For Fig. 5 , pairwise comparisons were made of transfected versus nontransfected cells at 0 and 3 h of Aβ exposure and of nontransfected cells at 0 versus 3 h of Aβ exposure.
Biochemical quantitation of unassembled and polymerized tubulin CV-1 cells and primary hippocampal neurons were treated with 1-3 μM prefi brillar or fi brillar Aβ42. Cells were washed briefl y with PBS and extracted with PHEM buffer (60 mM Pipes, pH 6.9, 25 mM Hepes, 10 mM EGTA, and 2 mM MgCl 2 ) with 10 μM taxol and 0.2% Triton X-100 for 5 min. The buffer was collected and centrifuged for 5 min at maximum speed in a table top centrifuge (model 5415; Eppendorf), and the supernatant was removed and mixed with 1/5 volume of 6× sample buffer for SDS-PAGE to generate a Triton-soluble fraction. An equivalent volume of PHEM buffer and 6× sample buffer was added to the dish, and this sample was added to the pellet from the spin to create a Triton-insoluble fraction. Equal volumes of Triton-soluble and -insoluble fractions, which contained soluble and polymerized tubulin, respectively (Black et al., 1996) , were then analyzed by immunoblotting with anti-α-tubulin. Quantitation of scanned immunoreactive bands was performed using ImageJ. Fig. S1 shows dot blots of prefi brillar and fi brillar Aβ42 and control proteins. Fig. S2 shows a Western blot of cell lysates from the scrambled siRNA-and tau siRNA-treated hippocampal neurons. Video 1 shows that microtubules disassemble in tau-expressing CV-1 cells exposed to prefi brillar Aβ42. Video 2 shows that microtubules disassemble in tau-expressing CV-1 cells exposed to prefi brillar Aβ40. Video 3 shows that tau is required for prefi brillar Aβ42 to induce microtubule disassembly. Video 4 demonstrates that fi brillar Aβ42 does not induce microtubule disassembly in tauexpressing cells. Video 5 shows that prefi brillar Aβ42 does not induce microtubule disassembly in MAP2c-expressing cells. Video 6 demonstrates that prefi brillar Aβ42 does not induce microtubule disassembly in cells expressing MAP2c chimera. Video 7 shows that prefi brillar Aβ42 induces microtubule disassembly in cells expressing tau chimera. Video 8 demonstrates that prefi brillar Aβ42 induces microtubule disassembly in cells expressing the N-terminal tau arm. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200605187/DC1.
Online supplemental material
